Home Newsletters Endothelial Cell News LncRNA LYPLAL1-DT Screening from Type 2 Diabetes with Macrovascular Complication Contributes Protective...

LncRNA LYPLAL1-DT Screening from Type 2 Diabetes with Macrovascular Complication Contributes Protective Effects on Human Umbilical Vein Endothelial Cells via Regulating the miR-204-5p/SIRT1 Axis

By
Danielle Corrigan
-
0
Researchers identified LYPLAL1-DT as having had protective effects on endothelial cells as competing endogenous RNA mediated through the miR-204-5p/SIRT1 pathway.
[Cell Death Discovery]
Full Article

RELATED ARTICLES

Exit mobile version